NKTR-102 Efficacy versus irinotecan in a mouse model of brain metastases of breast cancer

BACKGROUND: Brain metastases are an increasing problem in women with invasive breast cancer. Strategies designed to treat brain metastases of breast cancer, particularly chemotherapeutics such as irinotecan, demonstrate limited efficacy. Conventional irinotecan distributes poorly to brain metastases...

Descripción completa

Detalles Bibliográficos
Autores principales: Adkins, Chris E., Nounou, Mohamed I., Hye, Tanvirul, Mohammad, Afroz S., Terrell-Hall, Tori, Mohan, Neel K., Eldon, Michael A., Hoch, Ute, Lockman, Paul R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604629/
https://www.ncbi.nlm.nih.gov/pubmed/26463521
http://dx.doi.org/10.1186/s12885-015-1672-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604629/
https://www.ncbi.nlm.nih.gov/pubmed/26463521
http://dx.doi.org/10.1186/s12885-015-1672-4

Ejemplares similares